A Multicenter Observational Study of Whole Genome Analysis for patient benefit

A Multicenter Observational Study of Whole Genome Analysis for patient benefit - A Multicenter Observational Study of Whole Genome Analysis for patient benefit

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000049428

Enrollment

5000

Registered

2022-11-04

Start date

2022-10-04

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

cancer

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Patients with cancer, who underwent whole genome analysis in the "Research in Whole Genome Analysis of Cancer for patient"

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Percentage of patients with advanced or refractory cancer linked to treatment after whole genome analysis	—

Secondary

Measure	Time frame
Percentage of patients who will be diagnosed after whole genome analysis in particularly difficult-to-diagnose cancer types, including rare cancers. Percentage of patients for whom a heritable disease-associated pathological variant is extracted by whole genome analysis	—

Countries

Japan

Contacts

Public ContactYuki Katsuya

National Cancer Center Hospital Department of experimental development

ykatsuya@ncc.go.jp0335422511

Outcome results